Phage-Encoded Depolymerase DepKP144 with Therapeutic Potential Against Both K1- and K2-Type Klebsiella pneumoniae
International Journal of Molecular Sciences · 17.06.2026 · 27 (12) · 5466
DOI: 10.3390/ijms27125466 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 17.06.2026. Verfasst von Ekaterina A Kondakova und 8 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Chemical Biology and Fundamental Medicine Siberian Branch of Russian Academy of Sciences, 630090 Novosibirsk, Russia. Hauptthemen laut MEDLINE: Klebsiella pneumoniae, Klebsiella Infections, Bacteriophages, Anti-Bacterial Agents. Die Arbeit nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Russian Science Foundation, The Ministry of Education and Science of the Russian Federation, Ministry of Education and Science.
Abstract (Originalsprache)
Multidrug resistance (MDR) is a global problem for the healthcare system, complicating the therapy of bacterial infections. It is noted that patients infected with MDR strains often require prolonged hospitalization, have a high risk of mortality, and remain vulnerable to reinfection after recovery. In this study, recombinant phage-encoded depolymerase DepKP144 was produced using the Escherichia coli expression system and purified. The depolymerase DepKP144 protein was able to reduce viable bacterial counts following capsule degradation in 95% of the tested strains of type K1 and 85% of the tested strains of type K2 Klebsiella pneumoniae. The depolymerase DepKP144 was active against K. pneumoniae K1-type and K2-type planktonic cells and destroyed the biofilms formed by clinical MDR strains of K. pneumoniae. In in vivo experiments, DepKP144 at a dose of 180 μg/mouse resulted in a 50% survival of the mice infected with K2-type K. pneumoniae and in a 17% survival of the mice infected with K1-type K. pneumoniae. This depolymerase is promising for further development of prevention and therapeutic candidates against MDR K. pneumoniae.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Chemical Biology and Fundamental Medicine Siberian Branch of Russian Academy of Sciences, 630090 Novosibirsk, Russia.
- Faculty of Natural Sciences, Novosibirsk State University, 630090 Novosibirsk, Russia.
ORCID-Profile: Bogdana I Kravchuk, Yana A Khlusevich, Andrey L Matveev
Förderung
- Russian Science Foundation
- The Ministry of Education and Science of the Russian Federation
- Ministry of Education and Science
Zitieren
APA
Kondakova, E. A., Golosova, N. N., Kravchuk, B. I., Khlusevich, Y. A., Yakubovskij, V. I., Kozlova, Y. N., Grishkova, S. A., Tikunova, N. V., & Matveev, A. L. (2026). Phage-Encoded Depolymerase DepKP144 with Therapeutic Potential Against Both K1- and K2-Type Klebsiella pneumoniae. International Journal of Molecular Sciences, 27(12), 5466. https://doi.org/10.3390/ijms27125466
Vancouver
Kondakova EA, Golosova NN, Kravchuk BI, Khlusevich YA, Yakubovskij VI, Kozlova YN, et al. Phage-Encoded Depolymerase DepKP144 with Therapeutic Potential Against Both K1- and K2-Type Klebsiella pneumoniae. International Journal of Molecular Sciences. 2026;27(12):5466. doi:10.3390/ijms27125466
BibTeX
@article{Kondakova2026,
author = {Kondakova, Ekaterina A and Golosova, Natalia N and Kravchuk, Bogdana I and Khlusevich, Yana A and Yakubovskij, Vyacheslav I and Kozlova, Yuliya N and Grishkova, Svetlana A and Tikunova, Nina V and Matveev, Andrey L},
title = {Phage-Encoded Depolymerase DepKP144 with Therapeutic Potential Against Both K1- and K2-Type Klebsiella pneumoniae},
journal = {International Journal of Molecular Sciences},
year = {2026},
volume = {27},
number = {12},
pages = {5466},
doi = {10.3390/ijms27125466}
}
EUVIMED